Market Rally Drives Portfolio Gains Top and Bottom Performers Highlighted Intuit Shares Decline Amidst Market Concerns Over Growth Outlook Hindalco Faces Q4 Profit Halving but Bullish Metal Prices and Novelis Restart Lift MediumTerm Outlook US Stock Futures Bond Yields Decline After Reports Putin Updated Nuclear Doctrine Vickers Insider Trading Report Highlights Top Buyers and Sellers for May 27 2026 Healthcare and Tech Lift SP 500 as Communication Services Retreats NJR Q1 2026 Earnings EPS Surges Past Estimates with 14 Surprise Xometry Inc XMTR Q1 2026 Earnings Strong EPS Beat Amidst Limited Revenue Disclosure ADBE Q1 2026 Earnings EPS Tops Estimates Slightly Stock Edges Higher IBM Q1 2026 Earnings EPS Surpasses Estimates as Company Continues Strategic Transformation SNPS Q1 2026 Earnings Earnings Beat Estimates Stock Rises on Strong Performance Sanofi Shares Slip Potential Support Test Ahead for SNY The Beauty Health Company SKIN Holds Near Support A Cautious Stance at 079 TROOPS Inc TROO Surges Over 6 Testing Key Resistance at 428 Bain Capital Specialty Finance BCSF Shares Slip 08 Amid NearTerm Resistance Test iBio Inc IBIO Gains 266 as Stock Approaches Key Resistance Level Rithm Property Trust RPT Edges Higher as Support Holds Near 1391 Taiwan Semiconductor TSM Analysts Eye 430 Target Amid Projected 28 EPS Growth FRMI Q1 2026 Earnings Significant EPS Miss Despite Stock Uptick Mistral Explores InHouse Chip Design to Bolster AI Infrastructure CEO Reveals Ukraine Gymnastics Federation Seeks Emergency Congress Over FIG Rule Change on Russian Belarusian Athletes EMA Q1 2026 Earnings EPS Beats Estimates by 185 Shares Edge Lower CervoMed Inc CRVO Edges Lower as Stock Tests Support Near 300 SBAC Q1 2026 Earnings EPS Misses Estimates Amid Challenging Leasing Environment PTGX Q1 2026 Earnings Surprise Profit as Pipeline Advances Stock Edges Lower ESP Q1 2026 Earnings EPS Surges Past Estimates Stock Rises KRMN Q1 2026 Earnings EPS Miss Sends Shares Lower Amid Operational Challenges NRG Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds Stock Edges Higher C4 Therapeutics Q1 2026 Earnings Narrower Loss Surprises as Biotech Advances Pipeline GKOS Q1 2026 Earnings EPS Beat Masks Broader Concerns as Stock Drops 135